ArticleClinical lymphoma, myeloma & leukemia2025

Novel Neurocognitive Testing Tool for Early Neurotoxicity Detection Following Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-cell Therapy: A Pilot Study.

Arvind Suresh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.